HHS Should Issue Guidance On Research Involving Pregnant Women, Panel Recommends
This article was originally published in The Pink Sheet Daily
Executive Summary
Pregnant women are being arbitrarily excluded from behavioral and social science research, the HHS Secretary’s Advisory Committee on Human Research Protections finds. With the appropriate protections, there is no reason to exclude a woman from a trial if she becomes pregnant after enrolling, SACHRP says.
You may also be interested in...
“Pharmaco-Metabonomics” Holds Promise for Personalized Drug Therapies, Researchers Say
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.
NCI-Funded Researchers Are Patenting At Surprisingly High Rate, Report Says
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.
U.S. Overtakes Europe In New Drug Introductions, Study Finds
U.S. overtakes Europe in innovation between 1993 and 2003, introducing the most first-in-class, biotech and orphan products in the global market, according to a study authored by a Duke University economics professor